vs
ARDELYX, INC.（ARDX）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是ARDELYX, INC.的1.2倍（$117.7M vs $94.5M），Resolute Holdings Management, Inc.净利率更高（-1.5% vs -39.8%，领先38.3%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
ARDX vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.2倍
$94.5M
净利率更高
RHLD
高出38.3%
-39.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $117.7M |
| 净利润 | $-37.6M | $-1.7M |
| 毛利率 | — | 55.7% |
| 营业利润率 | — | 30.2% |
| 净利率 | -39.8% | -1.5% |
| 营收同比 | 27.5% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.15 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXRHLD
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $117.7M | ||
| Q3 25 | $110.3M | $120.9M | ||
| Q2 25 | $97.7M | $119.6M | ||
| Q1 25 | $74.1M | $103.9M | ||
| Q4 24 | $116.1M | — | ||
| Q3 24 | $98.2M | — | ||
| Q2 24 | $73.2M | — |
净利润ARDXRHLD
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $-1.7M | ||
| Q3 25 | $-969.0K | $-231.0K | ||
| Q2 25 | $-19.1M | $-611.0K | ||
| Q1 25 | $-41.1M | $-3.4M | ||
| Q4 24 | $4.6M | — | ||
| Q3 24 | $-809.0K | — | ||
| Q2 24 | $-16.5M | — |
毛利率ARDXRHLD
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 55.7% | ||
| Q3 25 | 96.4% | 59.0% | ||
| Q2 25 | 87.3% | 57.5% | ||
| Q1 25 | 83.4% | 52.5% | ||
| Q4 24 | 84.3% | — | ||
| Q3 24 | 84.0% | — | ||
| Q2 24 | 87.1% | — |
营业利润率ARDXRHLD
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 30.2% | ||
| Q3 25 | 4.2% | 34.3% | ||
| Q2 25 | -14.7% | 34.0% | ||
| Q1 25 | -49.0% | 24.7% | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | -18.6% | — |
净利率ARDXRHLD
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | -1.5% | ||
| Q3 25 | -0.9% | -0.2% | ||
| Q2 25 | -19.5% | -0.5% | ||
| Q1 25 | -55.5% | -3.2% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | -0.8% | — | ||
| Q2 24 | -22.5% | — |
每股收益（稀释后）ARDXRHLD
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | $-0.20 | ||
| Q3 25 | $0.00 | $-0.03 | ||
| Q2 25 | $-0.08 | $-0.07 | ||
| Q1 25 | $-0.17 | $-0.39 | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $0.00 | — | ||
| Q2 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | $205.5M |
| 总债务越低越好 | $203.5M | $169.8M |
| 股东权益账面价值 | $148.6M | $6.5M |
| 总资产 | $504.5M | $333.4M |
| 负债/权益比越低杠杆越低 | 1.37× | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资ARDXRHLD
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | $205.5M | ||
| Q3 25 | $42.7M | $148.0M | ||
| Q2 25 | $90.0M | $99.9M | ||
| Q1 25 | $30.8M | $71.0M | ||
| Q4 24 | $64.9M | — | ||
| Q3 24 | $47.4M | — | ||
| Q2 24 | $41.9M | — |
总债务ARDXRHLD
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | $169.8M | ||
| Q3 25 | $202.1M | $173.4M | ||
| Q2 25 | $201.4M | $177.1M | ||
| Q1 25 | $151.3M | $180.7M | ||
| Q4 24 | $150.9M | — | ||
| Q3 24 | $100.7M | — | ||
| Q2 24 | $100.2M | — |
股东权益ARDXRHLD
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $6.5M | ||
| Q3 25 | $154.3M | $10.8M | ||
| Q2 25 | $139.5M | $9.6M | ||
| Q1 25 | $145.7M | $8.9M | ||
| Q4 24 | $173.3M | — | ||
| Q3 24 | $158.3M | — | ||
| Q2 24 | $147.0M | — |
总资产ARDXRHLD
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $333.4M | ||
| Q3 25 | $486.2M | $293.2M | ||
| Q2 25 | $466.8M | $253.3M | ||
| Q1 25 | $410.2M | $214.3M | ||
| Q4 24 | $435.8M | — | ||
| Q3 24 | $367.9M | — | ||
| Q2 24 | $343.5M | — |
负债/权益比ARDXRHLD
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | 26.03× | ||
| Q3 25 | 1.31× | 16.01× | ||
| Q2 25 | 1.44× | 18.42× | ||
| Q1 25 | 1.04× | 20.38× | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $196.1M |
| 自由现金流经营现金流 - 资本支出 | — | $189.2M |
| 自由现金流率自由现金流/营收 | — | 160.8% |
| 资本支出强度资本支出/营收 | — | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $313.2M |
8季度趋势，按日历期对齐
经营现金流ARDXRHLD
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $196.1M | ||
| Q3 25 | $365.0K | $59.6M | ||
| Q2 25 | $-25.3M | $48.9M | ||
| Q1 25 | $-38.5M | $18.4M | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | $501.0K | — | ||
| Q2 24 | $-19.4M | — |
自由现金流ARDXRHLD
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | $189.2M | ||
| Q3 25 | $209.0K | $58.6M | ||
| Q2 25 | $-26.0M | $47.5M | ||
| Q1 25 | $-38.8M | $17.8M | ||
| Q4 24 | $9.2M | — | ||
| Q3 24 | $364.0K | — | ||
| Q2 24 | $-19.5M | — |
自由现金流率ARDXRHLD
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | 160.8% | ||
| Q3 25 | 0.2% | 48.5% | ||
| Q2 25 | -26.6% | 39.7% | ||
| Q1 25 | -52.3% | 17.1% | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | -26.7% | — |
资本支出强度ARDXRHLD
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 5.8% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | 0.7% | 1.2% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — |
现金转化率ARDXRHLD
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
RHLD
暂无分部数据
